Epstein-Barr virus recombinants from overlapping cosmid fragments.
about
An Epstein-Barr virus protein interacts with NotchEpstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling proteinThe Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaBA genetic system for rhesus monkey rhadinovirus: use of recombinant virus to quantitate antibody-mediated neutralization.Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells.Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirusConstruction and characterization of murine cytomegaloviruses that contain transposon insertions at open reading frames m09 and M83.In vitro and in vivo characterization of a murine cytomegalovirus with a transposon insertional mutation at open reading frame M43.Murine cytomegalovirus containing a mutation at open reading frame M37 is severely attenuated in growth and virulence in vivo.Murine cytomegalovirus open reading frame M27 plays an important role in growth and virulence in mice.The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.Immortalization of human primary B lymphocytes in vitro with DNA.Herpesvirus BACs: past, present, and future.Murine cytomegalovirus with a transposon insertional mutation at open reading frame m155 is deficient in growth and virulence in mice.The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.Recent advances in cloning herpesviral genomes as infectious bacterial artificial chromosomesMurine cytomegalovirus with a transposon insertional mutation at open reading frame M35 is defective in growth in vivo.Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs.Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells.The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.RNA virus vectors: where are we and where do we need to go?Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral ReplicationEpstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growthAn Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitroEpstein-Barr virus intrastrain recombination in oral hairy leukoplakia.The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.Epstein-Barr virus vectors for gene delivery to B lymphocytes.An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.Generation of mutant murine cytomegalovirus strains from overlapping cosmid and plasmid clones.Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus.The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformationInitiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids.Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells.Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigenEBV persistence without its EBNA3A and 3C oncogenes in vivo.
P2860
Q24529019-C1EC56BA-4205-4AD2-980E-728424946874Q24645568-1CDB9354-D67C-4717-8C4D-F6CA2775F7BAQ24646694-6971DE3D-2D55-43F7-8F44-32858ABD2929Q33231721-F34F9813-4463-4D13-AC48-7F044FD2D15AQ33650107-3AB130D4-4496-4834-B5B0-522277F1B5A8Q33796173-2B615546-2988-42FC-B93D-0B27DFE49C78Q33809617-1D4BDAB0-C019-4FA3-8806-E5193CC2EDA7Q33811459-E4CBE4F5-9857-4337-8C30-F3372598357EQ33826747-208C9599-5558-4E54-8D4A-706D8E5FF483Q33837391-C3CD763D-C855-4BA4-9E6C-D2A3EC1A3568Q33918592-199DBA52-F80E-405C-B309-CC307015B85FQ34160976-8E894AF0-CECF-4344-B91D-14E37512EAEEQ34247863-DE657C76-7B59-417D-AB1E-89DE0FB29161Q34437908-718CC1AA-7E26-4D32-A7C6-D99D2397D85BQ34711793-7091B2DC-15EC-4E5B-A9BD-0F372DE87AC8Q35045319-F73878AC-614D-404B-80C6-43EEFC7E21ACQ35105296-D20EFBA4-6C31-4811-A36C-1712D2231B73Q35829364-29EB00E3-09A6-4D67-8D63-73A2335482B1Q35832104-6B6442E0-C14B-4407-AF43-42C11E041FD6Q35870965-9EC83DB6-F9FA-4BCB-BD1C-E0D6CA9BE180Q35997566-14484964-C1F7-43F3-A72E-639153985BDAQ36080373-AFED419A-CA2D-4977-BD22-F7FA87253E96Q36173276-4ACDDDFE-1A0C-4540-B338-B57249943365Q36434206-E2C3F8AC-FD87-4512-B002-1DBA127FCF93Q36434290-375925C2-3C5D-4260-90E7-2B8C75C1A9B2Q36525145-1DDA8B8E-4671-4EE0-A433-B16BA1B5CE7FQ36628631-44FB8278-E1E7-4887-A0F2-3D7FF7210E1BQ36637806-450C55C4-265C-48A8-B8D3-6911F2D11A38Q36637817-3BB7C2E3-DC44-4B7D-A142-48C03A1E81BBQ37248930-9CD4F138-5FE6-4116-9FD5-7C1553557278Q38791533-267CEBE4-1944-4BD2-B875-B0D74720ECBBQ39539772-6132A490-937D-4D68-B901-08F6AE87F71FQ39595184-3A301DF0-BA4D-4438-980C-8DB13450C4AAQ39596927-6D721038-C3D5-45E4-AE7F-A038A37FFD06Q39612332-DA77E2A1-FACD-4C02-9CDC-9705B1268E15Q39873911-48A6240F-1DED-4B45-8056-104BE3B3D001Q39876626-04357C1B-AA10-475D-AD59-F2FFA6AE5818Q40541072-D8024C90-078C-46D0-8DB7-FCDE054FBD24Q52803943-1CBA16EA-66AE-4CA1-8944-CFCB93D03797
P2860
Epstein-Barr virus recombinants from overlapping cosmid fragments.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Epstein-Barr virus recombinants from overlapping cosmid fragments.
@ast
Epstein-Barr virus recombinants from overlapping cosmid fragments.
@en
type
label
Epstein-Barr virus recombinants from overlapping cosmid fragments.
@ast
Epstein-Barr virus recombinants from overlapping cosmid fragments.
@en
prefLabel
Epstein-Barr virus recombinants from overlapping cosmid fragments.
@ast
Epstein-Barr virus recombinants from overlapping cosmid fragments.
@en
P2093
P2860
P1433
P1476
Epstein-Barr virus recombinants from overlapping cosmid fragments.
@en
P2093
B Tomkinson
E Robertson
R Longnecker
R Yalamanchili
P2860
P304
P407
P577
1993-12-01T00:00:00Z